These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 32097969

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
    Tang P, Zhang J, Peng S, Yan X, Wang Y, Wang S, Zhang Y, Liu G, Xu J, Huang Y, Zhang D, Liu Q, Jiang J, Lan W.
    BMC Endocr Disord; 2023 Apr 07; 23(1):77. PubMed ID: 37029354
    [Abstract] [Full Text] [Related]

  • 7. Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing's syndrome.
    Meloche-Dumas L, Mercier F, Lacroix A.
    Best Pract Res Clin Endocrinol Metab; 2021 Mar 07; 35(2):101486. PubMed ID: 33637447
    [Abstract] [Full Text] [Related]

  • 8. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
    Maria AG, Tatsi C, Berthon A, Drougat L, Settas N, Hannah-Shmouni F, Bertherat J, Faucz FR, Stratakis CA.
    Endocr Relat Cancer; 2020 Sep 07; 27(9):509-517. PubMed ID: 32638579
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A genetic and molecular update on adrenocortical causes of Cushing syndrome.
    Lodish M, Stratakis CA.
    Nat Rev Endocrinol; 2016 May 07; 12(5):255-62. PubMed ID: 26965378
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia.
    Vassiliadi DA, Tsagarakis S.
    Endocr Relat Cancer; 2019 Oct 01; 26(10):R567-R581. PubMed ID: 32053747
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
    Boikos SA, Horvath A, Heyerdahl S, Stein E, Robinson-White A, Bossis I, Bertherat J, Carney JA, Stratakis CA.
    Horm Metab Res; 2008 May 01; 40(5):347-53. PubMed ID: 18491255
    [Abstract] [Full Text] [Related]

  • 18. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I.
    Clin Endocrinol (Oxf); 2008 Sep 01; 69(3):367-73. PubMed ID: 18419788
    [Abstract] [Full Text] [Related]

  • 19. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.
    Berthon A, Hannah-Shmouni F, Maria AG, Faucz FR, Stratakis CA.
    J Steroid Biochem Mol Biol; 2019 Jul 01; 191():105316. PubMed ID: 31014964
    [Abstract] [Full Text] [Related]

  • 20. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH).
    Giacché M, Panarotto A, Mori L, Poliani PL, Lanzi R, Lena MS, Castellano M.
    Mol Genet Genomic Med; 2023 Apr 01; 11(4):e2126. PubMed ID: 36727580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.